SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-314765
Filing Date
2022-12-29
Accepted
2022-12-29 16:14:56
Documents
13
Period of Report
2022-12-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d426713d8k.htm   iXBRL 8-K 28493
2 EX-99.1 d426713dex991.htm EX-99.1 15797
  Complete submission text file 0001193125-22-314765.txt   169827

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20221228.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20221228_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20221228_pre.xml EX-101.PRE 10805
7 EXTRACTED XBRL INSTANCE DOCUMENT d426713d8k_htm.xml XML 3267
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 221498998
SIC: 2834 Pharmaceutical Preparations